According to Paratek Pharmaceuticals 's latest financial reports the company's total debt is $0.25 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $0.25 B | 1.05% |
2021-12-31 | $0.25 B | 1.48% |
2020-12-31 | $0.25 B | -4.11% |
2019-12-31 | $0.26 B | 14.79% |
2018-12-31 | $0.22 B | 286.85% |
2017-12-31 | $59.18 M | 51.86% |
2016-12-31 | $38.97 M | 99.2% |
2015-12-31 | $19.56 M | |
2009-12-31 | $1.11 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Ultragenyx RARE | $43.16 M | -83.38% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $28.84 M | -88.90% | ๐บ๐ธ USA |
Agenus
AGEN | $78.01 M | -69.97% | ๐บ๐ธ USA |